Kyle Piskel $ADPT SEC Form 4 Insider Trading

Kyle Piskel has filed a total of 17 insider trades in $ADPT since 2021. Their most recent trade was a sale of 3,115 shares, made on May 18, 2026. Their largest trade was a sale of 162,820 shares, made on Nov 28, 2025. We estimate that they now own 256,725 shares of $ADPT, worth an estimated $7.0 million.

Insider Trading at $ADPT

There have been a total of 291 insider trades reported at $ADPT since 2021, with 0 shares purchased and 9.3 million shares sold. The most active insider traders in $ADPT stock have been Harlan S Robins, Julie Rubinstein, and Chad M Robins. The most recent trade was a sale of 7,869 shares reported by FRANCIS LO (Chief People Officer), made on Sep 16, 2026.

$ADPT Executives and Stock Owners with Insider Trades

• Harlan S Robins, Chief Scientific Officer

• Julie Rubinstein, President and COO

• Chad M Robins, CEO and Chairman

• Francis Lo, Chief People Officer

• R Mark Adams, Chief Operating Officer

• Chad M Cohen, Chief Financial Officer

• Stacy L Taylor, SVP and General Counsel

• Susan Bobulsky, Chief Commercial Officer, MRD

• Kyle Piskel, Chief Financial Officer

• Sharon Benzeno, Chief Commercial Ofc Imm Med

• Kyle Piskel, Principal Accounting Officer

• Nitin Sood, Chief Commercial Officer, MRD

• Tycho Peterson, Chief Financial Officer

• Julie Rubinstein, President

• Jyoti Palaniappan, SVP, Diagnostics, T-Detect

• Lance Baldo, Chief Medical Officer

• Sharon Benzeno, Chief Business Development Off

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.